Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ebola vaccine success highlights dilemma of testing on captive chimps to save wild apes

27.05.2014

The first conservation-specific vaccine trial on captive chimpanzees has proved a vaccine against Ebola virus is both safe and capable of producing a robust immune response in chimpanzees.

This unprecedented study, published in the journal PNAS, shows that 'orphan' vaccines - which never complete the expensive licensing process for human use - can be co-opted for use on wildlife and might be a godsend for highly endangered species such as gorillas and chimpanzees, say researchers.

They suggest that, by ending captive research in an effort to pay back an "ethical debt" to captive chimpanzees, the US Government is poised to "renege on an even larger debt to wild chimpanzees" at risk from viruses transmitted by tourists and researchers – as safety testing on captive chimpanzees is required before vaccines can be used in the wild.

"The ape conservation community has long been non-interventionist, taking a 'Garden of Eden' approach to modern medicine for wild animals, but we ended Eden by destroying habitats and spreading disease," said Dr Peter Walsh, the senior author on the study from the Division of Biological Anthropology, University of Cambridge, who conducted the trial at the New Iberia Research Centre in the US with researchers from the Centre, as well as the US Army, the University of Louisiana and the conservation charity Apes Incorporated (ApesInc.org).

"Half of deaths among chimps and gorillas that live in proximity to humans are from our respiratory viruses. For us it's a sore throat - for them it's death."

"We need to be pragmatic about saving these animals now before they are wiped out forever, and vaccination could be a turning point. But park managers are adamant - and rightly so at this stage - that all vaccines are tested on captive apes before deployment in the wild. This means access to captive chimpanzees for vaccine trials."

Infectious diseases pose extinction-level threats to African ape species on a par with poaching and habitat loss, say researchers, with populations continuing to be devastated by malaria, anthrax and "spillover" respiratory viruses - as well as massive Ebola outbreaks which had killed roughly one third of the world gorilla population by 2007.

They believe 'orphan' vaccines could be critical weapons in the fight for wild ape survival. But the ability to test new vaccines relies on research access to captive chimpanzees, and the study's authors argue that it is vital to retain captive chimpanzees for vaccine trials, not for human use, but to help save key species of wild apes from extinction.

The US Fish and Wildlife Service is now considering regulations that would end all biomedical testing on captive chimpanzees over the next few years - the US being the only developed country to allow such research. The study's authors believe that the US should establish a "humanely housed" captive chimpanzee population dedicated solely to conservation research.

The researchers administered captive chimpanzees with a new 'virus-like particle' (VLP) vaccine being developed by the biotech company Integrated Biotherapeutics for use on humans. While they did not challenge the vaccinated animals directly with Ebola, researchers tested whether antibodies harvested from the chimpanzees could protect mice against the deadly virus. They also monitored the chimpanzees in case the vaccine produced health complications.

Results showed that the vaccine is safe in chimpanzees. The vaccinated chimpanzees developed 'robust immune responses', with virus-specific antibodies detected as early as two to four weeks after the first vaccination in some animals and within two weeks of the second vaccination in all animals.

The authors note that these VLP vaccines currently require multiple administrations to reach "full potency", but could prove the difference between survival and extinction for species that are highly endangered or immunologically fragile but also easy to vaccinate.

"There is a large pool of experimental vaccines that show excellent safety and immunity profiles in primate trails but are never licensed for human use," said Walsh.

"We've demonstrated that it's feasible for very modestly funded ape conservationists to adapt these orphan vaccines into conservation tools, but the ability to trial vaccines on captive chimps is vital. Ours is the first conservation-related vaccine trial on captive chimpanzees – and it may be the last.

"Although Congress specifically instructed the National Institutes of Health (NIH) to consider the conservation value of captive chimpanzee research, no findings on its possible impact were presented. If the biomedical laboratories that have the facilities and inclination to conduct controlled vaccine trials 'liquidate' their chimpanzee populations, there will be nowhere left to do conservation-related trials."

Fred Lewsey | Eurek Alert!
Further information:
http://www.cam.ac.uk

Further reports about: Ebola ability animals ape apes captive chimpanzees humans populations tested trials vaccination vaccines viruses

More articles from Ecology, The Environment and Conservation:

nachricht Coorong Fish Hedge Their Bets for Survival
27.03.2015 | University of Adelaide

nachricht Greener Industry If Environmental Authorities Change Strategy
27.03.2015 | University of Gothenburg

All articles from Ecology, The Environment and Conservation >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Experiment Provides the Best Look Yet at 'Warm Dense Matter' at Cores of Giant Planets

In an experiment at the Department of Energy's SLAC National Accelerator Laboratory, scientists precisely measured the temperature and structure of aluminum as...

Im Focus: Energy-autonomous and wireless monitoring protects marine gearboxes

The IPH presents a solution at HANNOVER MESSE 2015 to make ship traffic more reliable while decreasing the maintenance costs at the same time. In cooperation with project partners, the research institute from Hannover, Germany, has developed a sensor system which continuously monitors the condition of the marine gearbox, thus preventing breakdowns. Special feature: the monitoring system works wirelessly and energy-autonomously. The required electrical power is generated where it is needed – directly at the sensor.

As well as cars need to be certified regularly (in Germany by the TÜV – Technical Inspection Association), ships need to be inspected – if the powertrain stops...

Im Focus: 3-D satellite, GPS earthquake maps isolate impacts in real time

Method produced by UI researcher could improve reaction time to deadly, expensive quakes

When an earthquake hits, the faster first responders can get to an impacted area, the more likely infrastructure--and lives--can be saved.

Im Focus: Atlantic Ocean overturning found to slow down already today

The Atlantic overturning is one of Earth’s most important heat transport systems, pumping warm water northwards and cold water southwards. Also known as the Gulf Stream system, it is responsible for the mild climate in northwestern Europe. 

Scientists now found evidence for a slowdown of the overturning – multiple lines of observation suggest that in recent decades, the current system has been...

Im Focus: Robot inspects concrete garage floors and bridge roadways for damage

Because they are regularly subjected to heavy vehicle traffic, emissions, moisture and salt, above- and underground parking garages, as well as bridges, frequently experience large areas of corrosion. Most inspection systems to date have only been capable of inspecting smaller surface areas.

From April 13 to April 17 at the Hannover Messe (hall 2, exhibit booth C16), engineers from the Fraunhofer Institute for Nondestructive Testing IZFP will be...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Conference On Regenerative Medicine 2015: Registration And Abstract Submission Now Open

25.03.2015 | Event News

University presidents from all over the world meet in Hamburg

19.03.2015 | Event News

10. CeBiTec Symposium zum Big Data-Problem

17.03.2015 | Event News

 
Latest News

Speech dynamics are coded in the left motor cortex

31.03.2015 | Life Sciences

100-million-year-old scale insect practiced brood care

31.03.2015 | Life Sciences

Discovery of two new species of primitive fishes discovered

31.03.2015 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>